These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Synthesis and antituberculosis activity of a novel series of optically active 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles. Sasaki H, Haraguchi Y, Itotani M, Kuroda H, Hashizume H, Tomishige T, Kawasaki M, Matsumoto M, Komatsu M, Tsubouchi H. J Med Chem; 2006 Dec 28; 49(26):7854-60. PubMed ID: 17181168 [Abstract] [Full Text] [Related]
23. [New tuberculostatics under experiment. Results and prospects]. Anastasatu C. Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1989 Dec 28; 38(2):99-107. PubMed ID: 2555909 [No Abstract] [Full Text] [Related]
24. The antituberculous activity of rifamycin SV. Nitti V. Helv Med Acta; 1965 Dec 28; 32(6):603-24. PubMed ID: 4958120 [No Abstract] [Full Text] [Related]
25. Experimental tuberculosis with African strains of various drug-resistance. Zykov MP, Frank GL, Roulet H, Poti SJ. Exp Pathol (Jena); 1972 Dec 28; 7(5):298-308. PubMed ID: 4660919 [No Abstract] [Full Text] [Related]
27. [The virulence of resistance strains of Mycobacterium tuberculosis for guinea pigs and experimental therapeutic effects of antitubercular agents on the animals infected by the resistant strains. II. Experimental therapeutic effect on guinea pigs infected by resistant strains of Mycobacterium tuberculosis]. Yan BS. Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1982 Aug 28; 5(4):206-8. PubMed ID: 6816558 [No Abstract] [Full Text] [Related]
30. [Experimental aspects of the antimycobacterial activity of rifampicin]. Blasi A, Di Perna A, Vinciguerra E. Arch Tisiol Mal Appar Respir; 1967 Nov 28; 22(11):943-66. PubMed ID: 4978601 [No Abstract] [Full Text] [Related]
32. [Case of liver tuberculosis requiring differentiation from liver metastasis of cancer]. Kobayashi K, Yano S, Ikeda T, Tokuda Y, Touge H, Ishikawa S, Takeyama H. Kekkaku; 2007 Mar 28; 82(3):185-8. PubMed ID: 17444122 [Abstract] [Full Text] [Related]
33. [Streptomycin in experimental tuberculosis of guinea pigs]. de Kantor IN, Croxatto OC, Cetrángolo A. Medicina (B Aires); 1979 Mar 28; 39(5):619-24. PubMed ID: 121147 [No Abstract] [Full Text] [Related]
34. [Virulence of rifampicin-resistant tubercle bacilli for experimental animals (preliminary report)]. Osato T, Shimizu H. Kekkaku; 1972 May 28; 47(5):129-34. PubMed ID: 4625370 [No Abstract] [Full Text] [Related]
35. The experimental induction of localised skeletal tuberculous lesions and their accessibility to streptomycin. Tuli SM, Brighton CT, Morton HE, Clark LW. J Bone Joint Surg Br; 1974 Aug 28; 56B(3):551-9. PubMed ID: 4213894 [No Abstract] [Full Text] [Related]
36. [Experimental study of rifampicin and ethambutol]. Kozulitsyna TI, Korotaev GA. Probl Tuberk; 1971 Aug 28; 49(1):64-8. PubMed ID: 5576515 [No Abstract] [Full Text] [Related]
37. New rifabutin analogs: synthesis and biological activity against Mycobacterium tuberculosis. Barluenga J, Aznar F, García AB, Cabal MP, Palacios JJ, Menéndez MA. Bioorg Med Chem Lett; 2006 Nov 15; 16(22):5717-22. PubMed ID: 16987658 [Abstract] [Full Text] [Related]
38. Bacteriologic basis of short-course chemotherapy for tuberculosis. Grosset J. Clin Chest Med; 1980 May 15; 1(2):231-41. PubMed ID: 6794976 [No Abstract] [Full Text] [Related]
39. [Investigation on failures in the treatment of pulmonary tuberculosis with rifampicin. Tuberculosis Research Committee. RYOKEN]. Kekkaku; 1984 Feb 15; 59(2):91-104. PubMed ID: 6431172 [No Abstract] [Full Text] [Related]
40. [Local therapeutic trials of various forms of extrapulmonary tuberculosis using rifampicin suspension]. Basacopol A, Burzoni FJ, Munteanu E. Maroc Med; 1974 May 15; 54(579):314-6. PubMed ID: 4444315 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]